CD47阻断通过抑制DNA修复基因表达来增强西斯普拉丁的敏感性
Xingqian Liu1,2, Jie Lun1, Jianxin Xu1
1Cancer Institute of the Affiliated Hospital of Qingdao University, Qingdao 266071, China.
Acta biochimica et biophysica Sinica
|December 11, 2025
概括
CD47 (分化集群47) 蛋白质通过调节DNA修复基因来促进化疗耐药性. 阻断CD47增强了西斯的作用.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- CD47是一种天生的免疫检查点蛋白质,可以抑制细胞化.
- CD47在化疗耐药性中的作用尚未完全理解.
- 新出现的证据表明CD47.7的非正规功能.
研究的目的:
- 为了研究CD47在西斯普拉丁耐药性中的作用.
- 阐明CD47影响化疗反应的分子机制.
- 评估结合CD47阻断与西斯的治疗潜力.
主要方法:
- 用多个癌症细胞系进行实验.
- 在西斯普拉丁治疗后研究的CD47表达变化.
- 采用了基因切除 (敲除) 和 CD47.7 的抗体阻断.
- 分析了DNA损伤标记物 (γH2AX,ATM酸化) 和DNA修复基因表达 (ERCC1,FANCA,BRCA2).
- 在体内评估了瘤抑制作用.
主要成果:
- 西斯普拉丁治疗通过ATM/NF-κB通路对CD47的表达进行上调.
- 基因切除或CD47阻断使癌细胞对思素敏感.
- CD47的枯竭增强了西斯普拉丁诱导的DNA损伤,并抑制了DNA修复基因表达.
- CD47阻断在体内协同增强西斯普拉丁的疗效和瘤抑制.
结论:
- CD47通过转录调节DNA修复通路来促进西斯普拉丁耐药性.
- 针对CD47与西斯普拉丁结合,提供了一个有前途的治疗策略.
- 这种双重方法可以克服免疫逃避并提高化疗的疗效.
相关概念视频
02:36DNA Damage can Stall the Cell Cycle
9.9K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.9K
02:36DNA Damage Can Stall the Cell Cycle
3.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.0K
02:23Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
02:34Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
01:23Negative Regulator Molecules
38.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.2K